欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
FI/H/0550/001
药品名称
Mirtazapin Teva 15 mg
活性成分
mirtazapine 15.0 mg
剂型
Orodispersible tablet
上市许可持有人
TEVA Sweden AB Järnvägsgatan 11 BOX 1070 25110 HELSINGBORG
参考成员国 - 产品名称
Finland (FI)
互认成员国 - 产品名称
Germany (DE)
Mirtazapin-TEVA 15 mg Schmelztabletten
Denmark (DK)
Belgium (BE)
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Austria (AT)
Mirtazapin TEVA 15 mg Schmelztabletten
France (FR)
Spain (ES)
Portugal (PT)
Italy (IT)
Sweden (SE)
Mirtazapin Teva
Norway (NO)
Lithuania (LT)
Mirtazapine-Teva 15mg burnoje disperguojamosios tabletės
Hungary (HU)
Mizapin Sol. tabletta
Czechia (CZ)
MIRTAZAPINE – TEVA DisTab 15 mg
Slovakia (SK)
Mirtazapine-Teva DisTab 15 mg
许可日期
2006/01/18
最近更新日期
2018/11/14
药物ATC编码
N06AX11 mirtazapine
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic [Article 10.1.(a)(iii), first paragraph]
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase